For Pharma
Biopharma loses billions to 95% immunology attrition. Our AI paratope clustering decodes BCR/TCR for leading efficacy/toxicity indicators. Partner with us to systematically increase your PTRS.
Human-Validated Target Discovery
Bypass the immunology paradox of flawed animal models. MyImmune maps epitope landscapes in human "elite controllers" to discover "Nature's Solutions"—naturally tolerated targets and potent binders. This drastically reduces preclinical attrition and ensures a proven therapeutic window before clinical entry.
Precision Stratification & "Early Switch"
Stop paying the cost of clinical failure. Our Futility Navigator predicts patient response to high-toxicity therapies at baseline with benchmark-leading accuracy. Enrich trials with guaranteed responders to maximize PTRS, and implement proactive "Early Switch" models to route predicted non-responders to alternative trials before toxicity occurs.
Clinical Trial Rescue & Enrichment
Salvage high-value assets in high-failure indications like NSCLC. Acting as a retrospective navigation system, MyImmune analyzes banked samples from failed or borderline trials to uncover biological responder signatures. Filtering out non-responders dramatically improves Hazard Ratios (HR) and rescues the asset's regulatory viability.
Lifecycle Exclusivity Extension
Build a "Diagnostic Fortress" to defend aging blockbusters against generic competition. Co-developing a proprietary AI Companion Diagnostic (CDx) enables originators to isolate "super-responders" and secure new method-of-use patents. This creates a closed algorithmic system that ties your drug label to a proprietary immune signature that generics cannot easily replicate.
Proactive Safety Prediction (Cell Therapy)
Unlock the safety of CAR-T and bispecifics. Decoding baseline immune repertoires reveals signatures predictive of severe toxic events like Cytokine Release Syndrome (CRS). This foresight enables risk-stratified dosing protocols, keeps INDs active, and safely expands trial eligibility to frailer populations.
De-Risk Your Pipeline & Maximize PTRS
Stop paying the cost of failure. Partner with MyImmune to deploy AI stratification, rescue high-value assets, and build your diagnostic fortress. Schedule a partnership appointment today.